seltorexant also known developmental code names orexin antagonist medication development treatment depression selective antagonist orexin receptor medication taken february seltorexant phase clinical trials treatment major depressive disorder mdd phase trials treatment also investigation treatment sleep apnea recent development reported seltorexant development minerva neurosciences johnson johnsons janssen seltorexant explored doses early clinical trials conducted far seltorexant found improve depression scores hamilton depression rating scale people mdd improve sleep onset total sleep time time awake sleep onset sleep efficiency people mdd andor seltorexant reported safe side effects seltorexant observed clinical trials far included somnolence fatigue dizziness headache abdominal discomfort seltorexant shows greater binding affinity receptor contrast orexin receptor antagonists like suvorexant lemborexant daridorexant dual orexin receptor antagonists seltorexant fast absorption time peak levels hours relatively short duration elimination halflife residual effects medication observed hours daytime pharmacokinetics seltorexant considered ideal sleep seltorexant metabolized cytochrome enzyme smallmolecule compound structurally related clinically used orexin receptor httpsenwikipediaorgwikiseltorexant